AAAAAA

   
Results: 1-12 |
Results: 12
COMPARISON OF ORAL 5-HT3-RECEPTOR ANTAGONISTS AND LOW-DOSE ORAL METOCLOPRAMIDE PLUS IM DEXAMETHASONE FOR THE PREVENTION OF DELAYED EMESIS IN HEAD AND NECK-CANCER PATIENTS RECEIVING HIGH-DOSE CISPLATIN
Authors: MANTOVANI G MACCIO A CURRELI L LAMPIS B GHIANI M BIANCHI A CONTU P
Citation: G. Mantovani et al., COMPARISON OF ORAL 5-HT3-RECEPTOR ANTAGONISTS AND LOW-DOSE ORAL METOCLOPRAMIDE PLUS IM DEXAMETHASONE FOR THE PREVENTION OF DELAYED EMESIS IN HEAD AND NECK-CANCER PATIENTS RECEIVING HIGH-DOSE CISPLATIN, Oncology Reports, 5(1), 1998, pp. 273-280
NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED SQUAMOUS-CELL HEAD ANDNECK-CARCINOMA - A MULTICENTER, PHASE-III, RANDOMIZED STUDY COMPARINGCISPLATIN PLUS 5-FLUOROURACIL [5-FU] WITH CISPLATIN PLUS 5-FU PLUS RECOMBINANT INTERLEUKIN-2
Authors: MANTOVANI G GEBBIA V AIROLDI M BUMMA C CONTU P BIANCHI A GHIANI M DESSI D MASSA E CURRELI L LAMPIS B LAI P MULAS C TESTA A PROTO E CADEDDU G TORE G
Citation: G. Mantovani et al., NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED SQUAMOUS-CELL HEAD ANDNECK-CARCINOMA - A MULTICENTER, PHASE-III, RANDOMIZED STUDY COMPARINGCISPLATIN PLUS 5-FLUOROURACIL [5-FU] WITH CISPLATIN PLUS 5-FU PLUS RECOMBINANT INTERLEUKIN-2, Cancer immunology and immunotherapy, 47(3), 1998, pp. 149-156
CLINICAL AND IMMUNOLOGICAL EVALUATION OF SCHIZOPHYLLAN (SPG) IN COMBINATION WITH STANDARD CHEMOTHERAPY IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: MANTOVANI G BIANCHI A CURRELI L GHIANI M ASTARA G LAMPIS B SANTONA MC DESSI D ESU S LAI P MASSA E MACCIO A PROTO E
Citation: G. Mantovani et al., CLINICAL AND IMMUNOLOGICAL EVALUATION OF SCHIZOPHYLLAN (SPG) IN COMBINATION WITH STANDARD CHEMOTHERAPY IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA, International journal of oncology, 10(1), 1997, pp. 213-221
CHEMOIMMUNOTHERAPY WITH WEEKLY CISPLATIN AND ETOPOSIDE PLUS S.C. RIL-2 PLUS ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN STAGE IIIB-IV NSCLC -PRELIMINARY-RESULTS ON CLINICAL-RESPONSE AND ON IMMUNOLOGICAL ASSESSMENT
Authors: MANTOVANI G MACCIO A LAI P ESU S MASSA E GHIANI M ASTARA G MANCA G MASSA D LAMPIS B SUCCU G PISANO M VERSACE R PUSCEDDU G
Citation: G. Mantovani et al., CHEMOIMMUNOTHERAPY WITH WEEKLY CISPLATIN AND ETOPOSIDE PLUS S.C. RIL-2 PLUS ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN STAGE IIIB-IV NSCLC -PRELIMINARY-RESULTS ON CLINICAL-RESPONSE AND ON IMMUNOLOGICAL ASSESSMENT, European journal of cancer, 33, 1997, pp. 1080-1080
NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC) - A MULTICENTER PHASE-III RANDOMIZED STUDY COMPARING CISPLATIN (CDDP)-FU WITH CDDP+5-FU PLUS RECOMBINANT INTERLEUKIN-2 (RIL 2) - PRELIMINARY-RESULTS(5)
Authors: MANTOVANI G AIROLDI M BIANCHI A GHIANI M SUCCU G MASSA D CURRELI L LAMPIS B LAI P CADEDDU G BUMMA C
Citation: G. Mantovani et al., NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC) - A MULTICENTER PHASE-III RANDOMIZED STUDY COMPARING CISPLATIN (CDDP)-FU WITH CDDP+5-FU PLUS RECOMBINANT INTERLEUKIN-2 (RIL 2) - PRELIMINARY-RESULTS(5), European journal of cancer, 33, 1997, pp. 57-57
CHEMOIMMUNOTHERAPY WITH WEEKLY CISPLATIN AND ETOPOSIDE PLUS SC RIL-2 PLUS ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN STAGE IIIB-IV NSCLC - PRELIMINARY-RESULTS ON CLINICAL-RESPONSE AND ON IMMUNOLOGICAL ASSESSMENT
Authors: MANTOVANI G MACCIO A LAI P ESU S MASSA E GHIANI M ASTARA G MANCA G MASSA D LAMPIS B SUCCU G PISANO M VERSACE R PUSCEDDU G
Citation: G. Mantovani et al., CHEMOIMMUNOTHERAPY WITH WEEKLY CISPLATIN AND ETOPOSIDE PLUS SC RIL-2 PLUS ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN STAGE IIIB-IV NSCLC - PRELIMINARY-RESULTS ON CLINICAL-RESPONSE AND ON IMMUNOLOGICAL ASSESSMENT, European journal of cancer, 33, 1997, pp. 58-58
IMPACT OF PSYCHOSOCIAL INTERVENTION ON THE QUALITY-OF-LIFE OF ELDERLYCANCER-PATIENTS
Authors: MANTOVANI G ASTARA G LAMPIS B BIANCHI A CURRELI L ORRU W CARPINIELLO B CARTA MG SORRENTINO M RUDAS N
Citation: G. Mantovani et al., IMPACT OF PSYCHOSOCIAL INTERVENTION ON THE QUALITY-OF-LIFE OF ELDERLYCANCER-PATIENTS, Psycho-oncology, 5(2), 1996, pp. 127-135
NEOADJUVANT (PRIMARY) ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENTOF LOCALLY ADVANCED LARYNGEAL CARCINOMA - LARYNX PRESERVATION AND CLINICAL-RESPONSE
Authors: MANTOVANI G GEBBIA V PROTO E COSSU F BIANCHI A CURRELI L GHIANI M MASSA E ASTARA G LAMPIS B DESSI D SANTONA MC
Citation: G. Mantovani et al., NEOADJUVANT (PRIMARY) ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENTOF LOCALLY ADVANCED LARYNGEAL CARCINOMA - LARYNX PRESERVATION AND CLINICAL-RESPONSE, International journal of oncology, 9(5), 1996, pp. 1035-1043
NEOADJUVANT ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED ORAL CAVITY AND OROPHARYNX CANCER - A TENTATIVE QUANTITATIVE-EVALUATION OF ORGAN PRESERVATION AND CLINICAL-RESPONSE
Authors: MANTOVANI G GEBBIA V PROTO E COSSU F BIANCHI A CURRELI L GHIANI M ASTARA G LAMPIS B DESSI D SANTONA MC MASSA E
Citation: G. Mantovani et al., NEOADJUVANT ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED ORAL CAVITY AND OROPHARYNX CANCER - A TENTATIVE QUANTITATIVE-EVALUATION OF ORGAN PRESERVATION AND CLINICAL-RESPONSE, International journal of oncology, 9(3), 1996, pp. 571-578
CHEMOIMMUNOTHERAPY FOR ADVANCED-STAGE MALIGNANCIES AND ITS IMPACT ON QUALITY-OF-LIFE - MULTIDIMENSIONAL EVALUATION IN 10 CANCER-PATIENTS
Authors: CURRELI L LAMPIS B SANTONA MC MANTOVANI G
Citation: L. Curreli et al., CHEMOIMMUNOTHERAPY FOR ADVANCED-STAGE MALIGNANCIES AND ITS IMPACT ON QUALITY-OF-LIFE - MULTIDIMENSIONAL EVALUATION IN 10 CANCER-PATIENTS, Supportive care in cancer, 4(6), 1996, pp. 462-464
EVALUATION BY MULTIDIMENSIONAL INSTRUMENTS OF HEALTH-RELATED QUALITY-OF-LIFE OF ELDERLY CANCER-PATIENTS UNDERGOING 3 DIFFERENT PSYCHOSOCIALTREATMENT APPROACHES - A RANDOMIZED CLINICAL-TRIAL
Authors: MANTOVANI G ASTARA G LAMPIS B BIANCHI A CURRELI L ORRU W CARTA MG CARPINIELLO B CONTU P RUDAS N
Citation: G. Mantovani et al., EVALUATION BY MULTIDIMENSIONAL INSTRUMENTS OF HEALTH-RELATED QUALITY-OF-LIFE OF ELDERLY CANCER-PATIENTS UNDERGOING 3 DIFFERENT PSYCHOSOCIALTREATMENT APPROACHES - A RANDOMIZED CLINICAL-TRIAL, Supportive care in cancer, 4(2), 1996, pp. 129-140
PRIMARY T-CELL CD30-POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA ASSOCIATED WITH ADULT-ONSET CELIAC-DISEASE AND PRESENTING WITH SKIN-LESIONS
Authors: MANTOVANI G ESU S ASTARA G LAMPIS B MACCIO A USAI P SANTACRUZ G MURA E FERRELI A
Citation: G. Mantovani et al., PRIMARY T-CELL CD30-POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA ASSOCIATED WITH ADULT-ONSET CELIAC-DISEASE AND PRESENTING WITH SKIN-LESIONS, Acta haematologica, 94(1), 1995, pp. 48-51
Risultati: 1-12 |